ArticleVeterinary medicine and science2026
Evaluation of Selected Brain Damage Biomarkers in the Determination of Brain Damage in Dogs With Neurological Distemper.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundCanine distemper is a disease with high morbidity and mortality in domestic and wild carnivores caused by Canine distemper virus (CDV). Respiratory, gastrointestinal, dermatological, ophthalmic, or neurological disorders occur in dogs with canine distemper. CDV replicates in the central nervous system and causes non-purulent encephalomyelitis. This causes damage to the brain and spinal cord.
objectivesThe aim of the study was to reveal brain damage caused by the canine distemper virus in dogs using selected brain damage biomarkers and to determine which of these biomarkers are diagnostically significant in detecting brain damage.
methodsThirty-six six dogs with neurological of distemper and 16 control uninfected dogs were included in the study. Dogs with neurological distemper have nasal discharge, myoclonus of the temporal, chest, back and leg muscles, hyperkeratosis of the tip of the nose and footpad (Hard-pad). The disease was diagnosed by CDV Ag ELISA test and Polymerase chain reaction (PCR) test. A complete blood count was performed on the blood sample with K-EDTA. Venous blood gas measurement was performed in heparinised blood samples. The concentrations of neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), creatine kinase BB (CK-BB), adrenomedullin (ADM), activin A (ACTA), immunoglobulin G (IgG) and immunoglobulin M (IgM) were measured in serum using canine-specific commercial enzyme-linked immunosorbent assay ELISA kits.
resultsSerum NSE, GFAP, CK-BB, IgG, and IgM concentrations in dogs with neurological distemper showed statistically significant increases compared to healthy dogs (p < 0.001), while no statistically significant differences were detected in ADM and ACTA concentrations (p > 0.05). There was a statistically significant increase in the WBC, LYM, and MON counts of dogs with neurological distemper compared to healthy dogs (p < 0.01).
conclusionsSerum NSE, GFAP, CK-BB, IgG and IgM concentrations were found to be significantly increased in dogs with neurological distemper. The results of this study indicate that NSE, GFAP, and CK-BB biomarkers may have diagnostic significance in determining brain damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.